Company Overview of Urigen Pharmaceuticals, Inc.
Urigen Pharmaceuticals, Inc., a development stage company, engages in the development and commercialization of therapeutic products for patients with urological disorders in North America. Its clinical stage product includes URG101, a bladder instillation for bladder pain syndrome/intersticial cystitis for men and women. The company is based in Wilmington, Delaware.
501 Silverside Road
Wilmington, DE 19809
Key Executives for Urigen Pharmaceuticals, Inc.
Urigen Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Medpace Medical Device, Inc.||United States|
|Global Biotechnologies, Inc.||United States|
|SIM Surgical Inc.||United States|
|ProlX Pharmaceuticals Corporation||United States|
|Associates of Cape Cod, Inc.||United States|
Recent Private Companies Transactions
July 3, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- Washington, DC | PwCPosted: Aug 20
- New York, NY | PwCPosted: Aug 20
- New Haven, CT | InventivPosted: Apr 17
Sponsored Financial Commentaries
To contact Urigen Pharmaceuticals, Inc., please visit www.urigen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.